By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Antisoma Inc. 

700 Technology Square
Suite 220
Cambridge  Massachusetts  W4 5YF  U.S.A.
Phone: 617-252-6100 Fax: 617-252-6101



Company News
Permanent Headcount Down to Nil at Antisoma Inc. (ASM.L) 5/24/2011 8:38:44 AM
Biothera Acquires MUC1 Anti-Cancer Monoclonal Antibody From Antisoma PLC (ASM.L) 3/10/2011 9:58:46 AM
Antisoma PLC (ASM.L)'s CEO and Finance Director Leave After Drug Setbacks 3/1/2011 6:42:20 AM
Antisoma PLC (ASM.L) Reports Half-Year Results for the Six Months to 31 December 2010 2/8/2011 8:25:31 AM
Antisoma PLC (ASM.L)'s Leukemia Drug Fails at Phase III 1/31/2011 7:10:04 AM
Antisoma PLC (ASM.L) ASH Meeting Update 12/2/2010 11:18:52 AM
Antisoma PLC (ASM.L)'s AS1413 Phase III AML Data Now Expected Q1 2011 11/30/2010 9:44:02 AM
Antisoma PLC (ASM.L) to Present at Piper Jaffray Health Care Conference on Tuesday, November 30 11/24/2010 9:31:57 AM
Novartis AG Stops Lung Cancer Drug Trial of ASA404, Developed in Partnership with Antisoma PLC (ASM.L), Books $120 Million Charge 11/11/2010 7:45:41 AM
Antisoma PLC (ASM.L) Awarded US Qualifying Therapeutic Discovery Project Grant Of USD 244K 11/8/2010 9:57:15 AM